Peginterferon λ for the treatment of patients admitted to hospital with COVID-19: a phase 2, placebo-controlled randomized trial.
Saved in:
| Title: | Peginterferon λ for the treatment of patients admitted to hospital with COVID-19: a phase 2, placebo-controlled randomized trial. |
|---|---|
| Authors: | Kandel C; Michael Garron Hospital, Toronto, Canada. Electronic address: christopher.kandel@tehn.ca., Biondi MJ; York University, Toronto, Canada; Toronto Centre for Liver Disease, University Health Network, Toronto, Canada., Gillrie M; University of Calgary, Cumming School of Medicine, Calgary, Canada., Taylor M; Michael Garron Hospital, Toronto, Canada., Barber B; Toronto Centre for Liver Disease, University Health Network, Toronto, Canada., Amiri L; Toronto Centre for Liver Disease, University Health Network, Toronto, Canada., Robinson T; University of Calgary, Cumming School of Medicine, Calgary, Canada., Powis J; Michael Garron Hospital, Toronto, Canada., Adhikari NK; Department of Critical Care Medicine, Sunnybrook Health Science Centre, Toronto, Canada; Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada., Kozak RA; Sunnybrook Health Science Centre, Toronto, Canada., Zahoor MA; Toronto Centre for Liver Disease, University Health Network, Toronto, Canada., Smookler D; Toronto Centre for Liver Disease, University Health Network, Toronto, Canada., Booth J; Toronto Centre for Liver Disease, University Health Network, Toronto, Canada., Jeganathan S; Toronto Centre for Liver Disease, University Health Network, Toronto, Canada., Stanislau E; Hospital das Clínicas Faculdade de Medicina da Universidade de São Paulo and Inspirali, São Paulo, Brazil., Gehring AJ; Toronto Centre for Liver Disease, University Health Network, Toronto, Canada., Hirode G; Toronto Centre for Liver Disease, University Health Network, Toronto, Canada., Noureldin S; Toronto Centre for Liver Disease, University Health Network, Toronto, Canada., Capraru C; Toronto Centre for Liver Disease, University Health Network, Toronto, Canada., Hansen B; Toronto Centre for Liver Disease, University Health Network, Toronto, Canada; Erasmus University, Rotterdam, The Netherlands., Feld JJ; Toronto Centre for Liver Disease, University Health Network, Toronto, Canada. |
| Source: | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2025 Dec; Vol. 31 (12), pp. 2048-2055. Date of Electronic Publication: 2025 Aug 14. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 9516420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-0691 (Electronic) Linking ISSN: 1198743X NLM ISO Abbreviation: Clin Microbiol Infect Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
